Gene · 10558
Papers1,447
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,447
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Description of the dermatoscopic features observed in sporotrichosis and American cutaneous leishmaniasis in a reference center in Rio de Janeiro, Brazil. | An Bras Dermatol | 2023 | 37481377 | PubTator, text mining | PubMed |
| Gene therapy and other novel treatment approaches for Charcot-Marie-Tooth disease. | Neuromuscul Disord | 2023 | 37455204 | PubTator, text mining | PubMed |
| Sex Differences in Sphingosine-1-Phosphate Levels Are Dependent on Ceramide Synthase 1 and Ceramidase in Lung Physiology and Tumor Conditions. | Int J Mol Sci | 2023 | 37446018 | PubTator, text mining | PubMed |
| Energy metabolism and maternal-fetal tolerance working in decidualization. | Front Immunol | 2023 | 37404833 | PubTator, text mining | PubMed |
| Antiviral Activity against SARS-CoV-2 of Conformationally Constrained Helical Peptides Derived from Angiotensin-Converting Enzyme 2. | ACS Omega | 2023 | 37387789 | PubTator, text mining | PubMed |
| Novel Mode of nanoLuciferase Packaging in SARS-CoV-2 Virions and VLPs Provides Versatile Reporters for Virus Production. | Viruses | 2023 | 37376634 | PubTator, text mining | PubMed |
| Novel Therapeutic Approaches in Inherited Neuropathies: A Systematic Review. | Pharmaceutics | 2023 | 37376074 | PubTator, text mining | PubMed |
| The First Large Deletion of ATL3 Identified in a Patient Presenting with a Sensory Polyneuropathy. | Biomedicines | 2023 | 37371660 | PubTator, text mining | PubMed |
| SPTLC1 p.Leu38Arg, a novel mutation associated with childhood ALS. | Biochim Biophys Acta Mol Cell Biol Lipids | 2023 | 37348646 | PubTator, text mining | PubMed |
| Ceramide sensing by human SPT-ORMDL complex for establishing sphingolipid homeostasis. | Nat Commun | 2023 | 37308477 | Swiss-Prot, curated | PubMed |
| E2F2 serves as an essential prognostic biomarker and therapeutic target for human renal cell carcinoma by presenting "E2F2/miR-16-5p/SPTLC1" schema. | Transl Oncol | 2023 | 37300925 | PubTator, text mining | PubMed |
| Expression of Ceramide-Metabolizing Enzymes in the Heart Adipose Tissue of Cardiovascular Disease Patients. | Int J Mol Sci | 2023 | 37298446 | PubTator, text mining | PubMed |
| De Novo Human Angiotensin-Converting Enzyme 2 Decoy NL-CVX1 Protects Mice From Severe Disease After Severe Acute Respiratory Syndrome Coronavirus 2 Infection. | J Infect Dis | 2023 | 37279654 | PubTator, text mining | PubMed |
| Recent progress of the genetics of amyotrophic lateral sclerosis and challenges of gene therapy. | Front Neurosci | 2023 | 37250416 | PubTator, text mining | PubMed |
| Circulating sphingolipids in heart failure. | Front Cardiovasc Med | 2023 | 37229233 | PubTator, text mining | PubMed |
| Hepatic deletion of serine palmitoyl transferase 2 impairs ceramide/sphingomyelin balance, bile acids homeostasis and leads to liver damage in mice. | Biochim Biophys Acta Mol Cell Biol Lipids | 2023 | 37224999 | PubTator, text mining | PubMed |
| Novel oral SPT inhibitor CH5169356 inhibits hepatic stellate cell activation and ameliorates hepatic fibrosis in mouse models of non-alcoholic steatohepatitis (NASH). | Pharmacol Res Perspect | 2023 | 37204099 | PubTator, text mining | PubMed |
| Inhibiting de novo ceramide synthesis restores mitochondrial and protein homeostasis in muscle aging. | Sci Transl Med | 2023 | 37196064 | PubTator, text mining | PubMed |
| The C10orf76-PI4KB axis orchestrates CERT-mediated ceramide trafficking to the distal Golgi. | J Cell Biol | 2023 | 37195633 | PubTator, text mining | PubMed |
| Epigenetic Mechanisms of Aging and Aging-Associated Diseases. | Cells | 2023 | 37190071 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10558/papers?page=6